On January 16, 2019, the McGill University Hospital Network Center of Excellence for Atopic Dermatitis hosted Dr. Robert Bissonnette, MD, of Innovaderm Research, for a keynote lecture on ‘New molecular targets for atopic disease: Learning from proof of concept trials in atopic dermatitis.’ Next, there was an afternoon round-table discussion with local experts, specialists and trainees. 

This event was followed by a Th2 Core Meeting, where immunologists from McGill (PhD, MD) discussed needs and collaborations. Attendees expressed interest in holding two small Th2 Core meetings per year.

supporting partner